| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/ART.1780330302 |
| P698 | PubMed publication ID | 2180403 |
| P2093 | author name string | Dayer JM | |
| Arend WP | |||
| P433 | issue | 3 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 305-315 | |
| P577 | publication date | 1990-03-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis | |
| P478 | volume | 33 |
| Q51494837 | 17β-estradiol aggravates temporomandibular joint inflammation through the NF-κB pathway in ovariectomized rats. |
| Q74147649 | 4'-Hydroxy aceclofenac suppresses the interleukin-1-induced production of promatrix metalloproteinases and release of sulfated-glycosaminoglycans from rabbit articular chondrocytes |
| Q51728959 | A correlative study of clinical and histological findings of revision hip arthroplasty for rheumatoid arthritis and inflammatory joint disease. |
| Q38988652 | A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis |
| Q38300479 | A novel cis-acting element required for lipopolysaccharide-induced transcription of the murine interleukin-1 beta gene |
| Q40932806 | A review on the strategies for the development and application of new anti-arthritic agents |
| Q68223818 | Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta |
| Q42527897 | Action of anti-inflammatory drugs on interleukin-1 beta-mediated glucose uptake by synoviocytes |
| Q41322816 | Acute phase proteins and transformed cells. |
| Q40394155 | Acute phase proteins in the monitoring of inflammatory disorders |
| Q35093636 | Adalimumab - a new TNF-alpha antibody for treatment of inflammatory joint disease |
| Q82742597 | Alpinia galanga extracts downregulate interleukin-1β-induced matrix metalloproteinases expression in human synovial fibroblasts |
| Q40153016 | An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance. |
| Q43061720 | Anakinra in the treatment of rheumatic disease |
| Q31089069 | Anakinra treatment of patients with rheumatoid arthritis |
| Q71877378 | Analysis of bcl-2+ lymphocyte subpopulations in inflammatory synovial infiltrates by a double-immunostaining technique |
| Q35327839 | Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications |
| Q35609675 | Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes. |
| Q45195260 | Anti-IL-1 alpha autoantibodies in patients with rheumatic diseases and in healthy subjects |
| Q74254814 | Anti-IL-1alpha autoantibodies in early rheumatoid arthritis |
| Q34907832 | Anti-inflammatory and antiarthritic activity of anthraquinone derivatives in rodents |
| Q39830725 | Anti-inflammatory mechanism of total glycosides of Acanthopanax Giraldii |
| Q39715934 | Anti-inflammatory properties of Septilin in lipopolysaccharide activated monocytes and macrophage |
| Q37253521 | Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis |
| Q33578174 | Antifibrotic action of interleukin-1 receptor antagonist in lapine monoarticular arthritis |
| Q41465391 | Antigen-presenting capacity of rheumatoid synovial fibroblasts. |
| Q37328072 | Antisense makes sense in engineered regenerative medicine |
| Q42274055 | Arachidonic acid metabolism in TNS-induced chronic and immunologic enteritis in rats, and the effect of 5-ASA. |
| Q37230126 | Are cytokines involved in osteoarthritic pathophysiology? |
| Q83195501 | Association between chronic periodontitis and rheumatoid arthritis: a hospital-based case-control study |
| Q30234766 | Asthma and the Risk of Rheumatoid Arthritis: An Insight into the Heterogeneity and Phenotypes of Asthma |
| Q28377542 | Auranofin inhibits interleukin-1beta-induced transcript of cyclooxygenase-2 on cultured human synoviocytes |
| Q37845987 | Autopathogenic correlation of periodontitis and rheumatoid arthritis. |
| Q72429411 | Basement membrane proteins in synovial membrane: distribution in rheumatoid arthritis and synthesis by fibroblast-like cells |
| Q77398059 | Biologic activities of IL-1 and its role in human disease |
| Q67897217 | Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1–stimulated cartilage erosion and chondrocyte responsiveness |
| Q34251859 | Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist |
| Q37765830 | Biologics in children's autoimmune disorders: efficacy and safety |
| Q41645798 | Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines |
| Q54543840 | Blood cell gene expression profiling in subjects with aggressive periodontitis and chronic arthritis. |
| Q35838748 | Bone densitometry measurements in early inflammatory disease |
| Q33564801 | Bone mass in patients with rheumatoid arthritis |
| Q33565191 | Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity |
| Q48511100 | CMNSG Guest Lecture. Interleukin-1, interleukin-1 receptor, and interleukin-1 receptor antagonist |
| Q40925647 | Canine rheumatoid arthritis and inflammatory cytokines |
| Q73090772 | Cartilage protection by nitric oxide synthase inhibitors after intraarticular injection of interleukin-1beta in rats |
| Q39561182 | Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extract. |
| Q72180817 | Characterization of the immunophenotype and functional properties of fibroblast-like synoviocytes in comparison to skin fibroblasts and umbilical vein endothelial cells |
| Q30839917 | Chemically modified ribozyme targeting TNF-alpha mRNA regulates TNF-alpha and IL-6 synthesis in synovial fibroblasts of patients with rheumatoid arthritis |
| Q78106005 | Chemokines, nitric oxide and antiarthritic effects of 9-(2-phosphonomethoxyethyl)adenine (Adefovir) |
| Q73313550 | Chondroprogenitor cells of synovial tissue |
| Q33564938 | Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine |
| Q34700316 | Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis |
| Q36098699 | Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein |
| Q34559795 | Clinical significance of cytokine determination in synovial fluid |
| Q33578257 | Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study |
| Q24304897 | Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte |
| Q49109080 | Coculture of human articular chondrocytes with peripheral blood mononuclear cells as a model to study cytokine-mediated interactions between inflammatory cells and target cells in the rheumatoid joint |
| Q67566552 | Comparative effects of tetrandrine and berbamine on subcutaneous air pouch inflammation induced by interleukin-1, tumour necrosis factor and platelet-activating factor |
| Q34017277 | Conjugated linoleic acid and bone biology |
| Q72920727 | Contrasting levels of in vitro cytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltration |
| Q34793001 | Coronary vasoconstriction in vitro in the hearts of polyarthritic rats: effectiveness of in vivo treatment with the endothelin receptor antagonist SB 209670 |
| Q35690247 | Curcumin-loaded colloidal carrier system: formulation optimization, mechanistic insight, ex vivo and in vivo evaluation |
| Q33973488 | Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy |
| Q35233161 | Cytokine abnormalities in inflammatory arthritis |
| Q45258734 | Cytokine and nitric oxide production in the acute phase of bacterial cell wall-induced arthritis |
| Q41209346 | Cytokine inhibitors in autoimmune disease |
| Q71475041 | Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis |
| Q42076167 | Cytokines in childhood rheumatic diseases |
| Q37453953 | Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance? |
| Q41133438 | Cytokines in osteoarthritis: mediators or markers of joint destruction? |
| Q48027852 | Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention |
| Q35733792 | Cytokines in the rheumatic diseases |
| Q38335184 | DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets. |
| Q35973747 | Damage control in rheumatoid arthritis. Hard-hitting, early treatment is crucial to curbing joint destruction |
| Q36055358 | Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis |
| Q43204418 | Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases |
| Q41190792 | Degradation of interleukin 1beta by matrix metalloproteinases. |
| Q72891566 | Detection of tumour necrosis factor alpha and interleukin-1 beta in the rheumatoid osteoarthritic cartilage-pannus junction by immunohistochemical methods |
| Q33564673 | Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue |
| Q43653915 | Diacerein suppresses the increase in plasma nitric oxide in rat adjuvant-induced arthritis |
| Q71319533 | Dietary marine lipids suppress continuous expression of interleukin-1 beta gene transcription |
| Q40878936 | Dietary n-3 fatty acids and therapy for rheumatoid arthritis |
| Q45890461 | Differential cytokine mRNA expression in human labial minor salivary glands in primary Sjögren's syndrome |
| Q43053758 | Differential expression and functional behaviour of the alpha v and beta 3 integrin subunits in cytokine stimulated fibroblast-like cells derived from synovial tissue of rheumatoid arthritis and osteoarthritis in vitro |
| Q72303289 | Differential induction of human monocyte transforming growth factor beta 1 production and its regulation by interleukin 4 |
| Q74497765 | Differential inhibitory effects of indomethacin, dexamethasone, and interferon-gamma (IFN-gamma) on IL-11 production by rheumatoid synovial cells |
| Q73065149 | Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor alpha and CD40 signals |
| Q70713946 | Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage |
| Q67476173 | Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis |
| Q73374754 | Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis |
| Q40493960 | Dual biological functions of an interleukin-1 receptor antagonist-interleukin-10 fusion protein and its suppressive effects on joint inflammation |
| Q33745949 | Early diagnosis and treatment of rheumatoid arthritis for improved outcomes: focus on etanercept, a new biologic response modifier |
| Q41007640 | Effect of estrogens on IL-1beta promoter activity |
| Q38762138 | Effect of nonsurgical periodontal treatment in patients with periodontitis and rheumatoid arthritis: A systematic review |
| Q78109104 | Effects of antirheumatic drugs on adhesiveness of endothelial cells and neutrophils |
| Q46406275 | Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis |
| Q41271283 | Effects of interleukin-1 beta on insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes |
| Q45085691 | Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis |
| Q74273547 | Effects of nonsteroidal anti-inflammatory drugs on interleukin-1 receptor antagonist production in cultured human peripheral blood mononuclear cells |
| Q35821357 | Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis |
| Q38329070 | Enhancement of phosphorylation and transcriptional activity of the glucocorticoid receptor in human synovial fibroblasts by nimesulide, a preferential cyclooxygenase 2 inhibitor |
| Q40972088 | Establishment and characterization of nurse cell-like stromal cell lines from synovial tissues of patients with rheumatoid arthritis |
| Q37140765 | Etanercept Promotes Bone Formation via Suppression of Dickkopf-1 Expression in Rats with Collagen-Induced Arthritis. |
| Q82455857 | Etanercept treatment reduces the serum levels of interleukin-15 and interferon-gamma inducible protein-10 in patients with rheumatoid arthritis |
| Q34591536 | Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states |
| Q34256337 | Evaluation of Protective Efficacy of Avicennia marina (Forssk.) Vierh Leaves against Complete Freund᾽s Adjuvant-induced Arthritis in Wistar. |
| Q47692758 | Evaluation of disease-mediated therapeutic protein-drug interactions between an anti-interleukin-6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach |
| Q71877370 | Evaluation of interleukin-6 in rheumatoid arthritis as an activity criterion |
| Q38651509 | Evidence that TNF-β (lymphotoxin α) can activate the inflammatory environment in human chondrocytes |
| Q72920372 | Evidence that interleukin-1 mediates its effects on bone resorption via the 80 kilodalton interleukin-1 receptor |
| Q40643961 | Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis |
| Q58064608 | Expression and functional significance of an activation-dependent epitope of the beta 1 integrins in chronic inflammatory diseases |
| Q47776925 | Expression of activation-induced, T cell-derived, and chemokine-related cytokine/lymphotactin and its functional role in rheumatoid arthritis |
| Q28208076 | Expression of alternatively spliced interleukin-1 receptor accessory protein mRNAs is differentially regulated during inflammation and apoptosis |
| Q71018485 | Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA) |
| Q73149123 | Expression of interleukin-4 and interferon-gamma in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy |
| Q71645876 | Expression of the chemokine superfamily in rheumatoid arthritis |
| Q72778064 | Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium |
| Q72072827 | Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines |
| Q83202778 | FK506 inhibition of gliostatin/thymidine phosphorylase production induced by tumor necrosis factor-α in rheumatoid fibroblast-like synoviocytes |
| Q42159855 | Fibronectin-fragment-induced cartilage chondrolysis is associated with release of catabolic cytokines |
| Q71602337 | Functional analysis of synovial fluid and peripheral blood T cells from patients with rheumatoid arthritis |
| Q44091872 | Functional changes in rheumatoid fibroblast-like synovial cells through activation of peroxisome proliferator-activated receptor gamma-mediated signalling pathway |
| Q71692247 | G-CSF in Felty's syndrome: correction of neutropenia and effects on cytokine release |
| Q77643027 | GCF IL-1beta profiles in periodontal disease |
| Q67539003 | GMP-140 (P-selectin/CD62) binds to chronically stimulated but not resting CD4+ T lymphocytes and regulates their production of proinflammatory cytokines |
| Q34328705 | Ganglioside GM3 has an essential role in the pathogenesis and progression of rheumatoid arthritis. |
| Q45885240 | Gene targeting by ribozyme against TNF-alpha mRNA inhibits autoimmune arthritis |
| Q77786312 | Gene therapy for rheumatoid arthritis |
| Q34385774 | Gene therapy: future therapies in osteoarthritis. |
| Q44213356 | Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy |
| Q37582905 | Glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, inhibits the progression of group B streptococcal arthritis |
| Q46250526 | Hecogenin exhibits anti-arthritic activity in rats through suppression of pro-inflammatory cytokines in Complete Freund's adjuvant-induced arthritis |
| Q59880008 | High levels of Lymphotoxin-Beta (LT-Beta) gene expression in rheumatoid arthritis synovium: clinical and cytokine correlations |
| Q70864726 | Histamine-stimulated production of matrix metalloproteinase 1 by human rheumatoid synovial fibroblasts is mediated by histamine H1-receptors |
| Q36735470 | Histomorphometric Evaluation of Cartilage Degradation using Rabbit Articular Chondrocytes Cultured in Alginate Beads - Effects of Hyaluronan |
| Q37842633 | How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? |
| Q40594302 | Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity |
| Q46029216 | Human recombinant interleukin-1 receptor antagonist blocks bone resorption induced by interleukin-1 beta but not interleukin-1 alpha. |
| Q42136310 | Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies. |
| Q48255071 | Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis |
| Q43203799 | ICAM-1 expression on chondrocytes in rheumatoid arthritis: induction by synovial cytokines |
| Q72611609 | IL-1 beta and IL-6 stimulate the production of platelet-activating factor (PAF) by cultured rabbit synovial cells |
| Q42460838 | IL-1 beta, a strong mediator for glucose uptake by rheumatoid and non-rheumatoid cultured human synoviocytes |
| Q24291729 | IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding |
| Q67900835 | IL-1ra ELISA: reduction and alkylation of synovial fluid eliminates interference by IgM rheumatoid factors |
| Q60718581 | Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease |
| Q73417844 | Imbalance of tissue-type plasminogen activator (t-PA) and its specific inhibitor (PAI-1) in patients with rheumatoid arthritis associated with disease activity |
| Q35153751 | Immune responses in cancer |
| Q33655250 | Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt? |
| Q44308187 | Immunomodulatory activity of the aqueous extract from rhizome of Smilax glabra in the later phase of adjuvant-induced arthritis in rats |
| Q50457343 | Immunomodulatory effect of tea saponin in immune T-cells and T-lymphoma cells via regulation of Th1, Th2 immune response and MAPK/ERK2 signaling pathway. |
| Q81809220 | Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells |
| Q72753027 | Immunosuppressive agents |
| Q28366784 | Importance of NF-kappaB in rheumatoid synovial tissues: in situ NF-kappaB expression and in vitro study using cultured synovial cells |
| Q53293050 | In vitro effect of different mediators of apoptosis on canine cranial and caudal cruciate ligament fibroblasts and its reversibility by pancaspase inhibitor zVAD.fmk |
| Q35596079 | In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. |
| Q72079773 | Increased percentage of cd3+, cd57+ lymphocytes in patients with rheumatoid arthritis. correlation with duration of disease |
| Q33565980 | Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis |
| Q37129859 | Indian herbal medicines: possible potent therapeutic agents for rheumatoid arthritis |
| Q55241747 | Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. |
| Q33905638 | Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells |
| Q73363917 | Influence of interferon-gamma administration on the severity of experimental group B streptococcal arthritis |
| Q40854027 | Inhibition of L-leucine methyl ester mediated killing of THP-1, a human monocytic cell line, by a new anti-inflammatory drug, T614. |
| Q67915942 | Inhibition of tumour necrosis factor alpha (TNF-alpha)-induced neutrophil respiratory burst by a TNF inhibitor |
| Q77849071 | Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells |
| Q43203925 | Inhibitory effects of bisbenzylisoquinolines on synthesis of the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha |
| Q73519432 | Inhibitory effects of interleukin-10 on synovial cells of rheumatoid arthritis |
| Q35611443 | Integrative omics analysis of rheumatoid arthritis identifies non-obvious therapeutic targets |
| Q67905208 | Interaction of recombinant monocyte-derived interleukin 1 receptor antagonist with rheumatoid synovial cells |
| Q46626463 | Interleukin 1 and phorbol 12-myristate 13-acetate induce collagenase and PGE2 production through a PKC-independent mechanism in chondrocytes |
| Q71971863 | Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint |
| Q42862057 | Interleukin 1 induces the expression of a heat-shock gene in chondrocytes |
| Q28571336 | Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism |
| Q24630432 | Interleukin 1 receptor antagonist. A new member of the interleukin 1 family |
| Q47970081 | Interleukin pattern of Apert fibroblasts in vitro |
| Q61649588 | Interleukin-1 beta, plasminogen activator and inhibitor of plasminogen activator in synovial fluid of rheumatoid arthritis, psoriatic arthritis and osteoarthritis |
| Q34354989 | Interleukin-1 receptor antagonist |
| Q77386532 | Interleukin-1 receptor antagonist expression in epithelial cells of human endometrium |
| Q41285681 | Interleukin-1 receptor antagonist production in cultured synovial cells from patients with rheumatoid arthritis and osteoarthritis |
| Q37768849 | Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis |
| Q35675887 | Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis? |
| Q47632515 | Interleukin-1beta and tumor necrosis factor-alpha produce distinct, time-dependent patterns of acute arthritis in the rat knee |
| Q73779446 | Interleukin-1beta in antigen-induced arthritis of the rabbit temporomandibular joint |
| Q33578993 | Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I. |
| Q39811703 | Interleukin-4 inhibits secretion of interleukin-1beta in the response of human cells to mycobacterial heat shock proteins. |
| Q41636231 | Interleukin-6 can prime THP-1 macrophages for enhanced production of tumor necrosis factor-α in response to LPS |
| Q36626997 | Interleukin-6 in peripheral blood and inflammatory sites in Behçet's disease |
| Q41282394 | Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid |
| Q73117129 | Intraarticular osteoid osteoma associated with synovitis: a possible role of cyclooxygenase-2 expression by osteoblasts in the nidus |
| Q42843832 | Intrathecal eugenol administration alleviates neuropathic pain in male Sprague‐Dawley rats |
| Q60054286 | Investigating sirukumab for rheumatoid arthritis: 2-year results from the phase III SIRROUND-D study |
| Q74459585 | Involvement of leukotriene B4 in arthritis models |
| Q44004839 | Involvement of platelet-activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits |
| Q35548076 | Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1, for synovial cell outgrowth in patients with rheumatoid arthritis |
| Q34276089 | JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy |
| Q34626968 | Juvenile rheumatoid arthritis: therapeutic perspectives |
| Q34792751 | Kallikrein cascade and cytokines in inflamed joints |
| Q67545665 | Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls |
| Q37054152 | Krüppel-Like Factor 4 Is a Regulator of Proinflammatory Signaling in Fibroblast-Like Synoviocytes through Increased IL-6 Expression. |
| Q41834519 | Lack of involvement of lipocortin 1 in dexamethasone suppression of IL-1 release |
| Q35609090 | Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids |
| Q72592180 | Levels of soluble receptors for tumor necrosis factor type I and type II in paired synovial fluids of arthritis patients |
| Q44786503 | Lipoxin A4 counteracts synergistic activation of human fibroblast-like synoviocytes |
| Q35821863 | Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist |
| Q72429133 | Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis |
| Q79815230 | Long-term results of arthrocentesis in degenerative temporomandibular disorders |
| Q37921382 | Lymphotoxin α revisited: general features and implications in rheumatoid arthritis |
| Q40783444 | M1-like Macrophage Polarization Promotes Orthodontic Tooth Movement |
| Q35548569 | Macrophage inflammatory protein 1 alpha expression by synovial fluid neutrophils in rheumatoid arthritis |
| Q34129985 | Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis |
| Q38127779 | Macrophage subsets and osteoimmunology: tuning of the immunological recognition and effector systems that maintain alveolar bone |
| Q35838787 | Management of early inflammatory arthritis. Intervention with immunomodulatory agents: new pharmacological developments |
| Q40808203 | Marginal periodontitis and cytokines: a review of the literature |
| Q33578511 | Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies |
| Q42028453 | Mechanism of pentoxifylline mediated down-regulation of killer lineage cell functions |
| Q36067667 | Mechanisms of differential immunogenicity of tumor necrosis factor inhibitors |
| Q77385596 | Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA) |
| Q43185096 | Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities |
| Q45875458 | Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery |
| Q37047237 | Molecular insights into rheumatoid arthritis |
| Q24337005 | Molecular modelling of the Norrie disease protein predicts a cystine knot growth factor tertiary structure |
| Q39860550 | Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line |
| Q34236293 | Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis |
| Q57780174 | Neutrophil expression of tumour necrosis factor receptors (TNF-R) and of activation markers (CD11b, CD43, CD63) in rheumatoid arthritis |
| Q41837758 | Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage |
| Q40642412 | Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages |
| Q40882639 | Nuclear factor-kappaB and caspases co-operatively regulate the activation and apoptosis of human macrophages |
| Q39366351 | Nucleoprotein Diet Ameliorates Arthritis Symptoms in Mice Transgenic for Human T-Cell Leukemia Virus Type I (HTLV-1) |
| Q34402915 | Nutraceutical fatty acids as biochemical and molecular modulators of skeletal biology |
| Q35838702 | Objectives and outcome of running an early inflammatory arthritis clinic |
| Q33782360 | PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases |
| Q43822295 | PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts |
| Q34275978 | Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts. |
| Q35084709 | Pathologic thrombopoiesis of rheumatoid arthritis |
| Q41129525 | Pathways of destruction in metacarpal and metatarsal joints of patients with rheumatoid arthritis |
| Q51726032 | Patient demographics and disease variables correlate with distinct cytokine patterns in mitogen-stimulated peripheral blood mononuclear cells from rheumatoid arthritis patients. |
| Q39807877 | Patient with Takayasu arteritis presented as cardiogenic shock |
| Q34060781 | Periodontal status of rheumatoid arthritis patients in khartoum state |
| Q36309246 | Periodontitis and rheumatoid arthritis: a review. |
| Q72303278 | Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta |
| Q38357886 | Pharmaceutical aspects of anti-inflammatory TNF-blocking drugs |
| Q46102667 | Pharmacokinetic study and Fcgamma receptor gene analysis in two patients with rheumatoid arthritis controlled by low-dose infliximab |
| Q24793076 | Phenotypic characteristics of human monocytes undergoing transendothelial migration |
| Q40874634 | Phospholipase A2 and arthritis |
| Q42503198 | Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes |
| Q54000450 | Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen. |
| Q41376911 | Preferential production of interleukin-1 beta over interleukin-1 receptor antagonist contributes to proliferation and suppression of apoptosis in leukemic cells |
| Q72873794 | Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits |
| Q73305597 | Production of adrenomedullin from synovial cells in rheumatoid arthritis patients |
| Q40942545 | Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis |
| Q24803611 | Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies |
| Q74316253 | Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders |
| Q40968027 | Prospects of immunotherapy for rheumatoid arthritis |
| Q37370833 | Psychological stress alters the ultrastructure and increases IL-1β and TNF-α in mandibular condylar cartilage |
| Q48232259 | Psychological stress induces alterations in temporomandibular joint ultrastructure in a rat model of temporomandibular disorder |
| Q28570898 | RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies |
| Q67566554 | RP 54745, a potential antirheumatic compound. I. Inhibitor of macrophage stimulation and interleukin-1 production |
| Q34379763 | Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry |
| Q72069143 | Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis |
| Q35225283 | Regulation of early complement components C3 and C4 in the synovium |
| Q33179130 | Regulation of synovial cell apoptosis by proteasome inhibitor |
| Q47985931 | Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors |
| Q34364832 | Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2. |
| Q41876321 | Rheumatoid arthritis and the role of oral bacteria. |
| Q41209304 | Rheumatoid arthritis as a bone marrow disorder |
| Q34706975 | Rheumatoid arthritis: developing pharmacological therapies |
| Q37120627 | Rheumatoid arthritis: strategies in the management of patients showing an inadequate response to TNFalpha antagonists |
| Q73824455 | Role of interleukin-1 in induction of matrix metalloproteinases synthesized by rat temporomandibular joint chondrocytes and disc cells |
| Q44041992 | Role of macrophages in experimental group B streptococcal arthritis |
| Q77627732 | Role of pro-inflammatory cytokines in rheumatoid arthritis |
| Q34001731 | Role of tumor necrosis factor alpha, interleukin-1beta, and interleukin-6 in a mouse model of group B streptococcal arthritis |
| Q58831756 | Role of tumor necrosis factor-α and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis |
| Q51434788 | Running decreases knee intra-articular cytokine and cartilage oligomeric matrix concentrations: a pilot study. |
| Q36243349 | Salivary TNFα levels in groups of subjects with rheumatoid arthritis and chronic periodontitis |
| Q35933890 | Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health |
| Q72089118 | Selective localization of interleukin-1 receptor antagonist in eutopic endometrium and endometriotic implants |
| Q70968499 | Sera from patients with systemic lupus erythematosus demonstrate enhanced IgG binding to endothelial cells pretreated with tumour necrosis factor alpha |
| Q36476632 | Serum Copper as a Marker of Disease Activity in Rheumatoid Arthritis |
| Q36330162 | Serum corticosterone, interleukin-1 and tumour necrosis factor in rat experimental endotoxaemia: comparison between Lewis and Wistar strains |
| Q72002723 | Serum cytokines in patients with rheumatoid arthritis. Correlation of interferon gamma and tumor necrosis factor alpha with the characteristics of peripheral blood mononuclear cells |
| Q72511971 | Serum levels of interleukin 1-beta, tumor necrosis factor-alpha, soluble interleukin 2 receptor and soluble CD8 in seronegative spondylarthropathies |
| Q44974517 | Serum levels of interleukin-1b, tumour necrosis factor-a and interleukin-2 in rheumatoid arthritis. Correlation with disease activity |
| Q60912322 | Significant association between joint ultrasonographic parameters and synovial inflammatory factors in rheumatoid arthritis |
| Q38371450 | Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study |
| Q35173468 | Sleep deprivation induces abnormal bone metabolism in temporomandibular joint |
| Q46460363 | Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: impact of TNF-alpha |
| Q71858438 | Stimulation of enzyme and cytokine production by methyl mercaptan in human gingival fibroblast and monocyte cell cultures |
| Q36268846 | Strategies for the development of new antiarthritic agents |
| Q42713846 | Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium |
| Q42910608 | Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines |
| Q45864343 | Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy |
| Q46304671 | Synergistic effect of Kalpaamruthaa on antiarthritic and antiinflammatory properties--its mechanism of action |
| Q74165395 | Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease |
| Q35551058 | Synovial macrophage-osteoclast differentiation in inflammatory arthritis |
| Q39203484 | Synthesis and biological evaluation of asymmetric indole curcumin analogs as potential anti-inflammatory and antioxidant agents. |
| Q41452516 | T-cells in the pathogenesis of rheumatoid arthritis villains or accomplices? |
| Q37104019 | Takayasu's disease: a review |
| Q37224863 | The -174G/C and -572G/C interleukin 6 promoter gene polymorphisms in mexican patients with rheumatoid arthritis: a case-control study |
| Q57232115 | The Effect of Azathioprine on Serum Levels of Interleukin 6 and Soluble Interleukin 2 Receptor |
| Q36245861 | The Sp1 transcription factor is essential for the expression of gliostatin/thymidine phosphorylase in rheumatoid fibroblast-like synoviocytes. |
| Q40394146 | The acute phase response: General aspects |
| Q73542194 | The analysis of in vitro transforming growth factor-beta1 (TGF-beta1) production by peripheral blood in overt and pre-clinical type 1 diabetes mellitus |
| Q77838774 | The beneficial effect of interleukin-12 on arthritis induced by group B streptococci is mediated by interferon-gamma and interleukin-10 production |
| Q28251734 | The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis |
| Q35998746 | The course and outcome of rheumatoid arthritis. Radiological measures of outcome |
| Q34736462 | The disablement process in rheumatoid arthritis |
| Q41261950 | The effect of free gallium and gallium in liposomes on cytokine and nitric oxide secretion from macrophage-like cells in vitro |
| Q72068462 | The effect of interleukin‐1 on cytokine gene expression in cultured human articular chondrocytes analyzed by messenger rna phenotyping |
| Q70907139 | The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A |
| Q43494262 | The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis |
| Q50221142 | The expression of matrix metalloproteinases and their inhibitors in corneal fibroblasts by alarmins from necrotic corneal epithelial cells |
| Q34551313 | The identification of CD163 expressing phagocytic chondrocytes in joint cartilage and its novel scavenger role in cartilage degradation |
| Q35749882 | The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor |
| Q81256806 | The long-term effect of anti TNF-alpha treatment on temporomandibular joints, oral mucosa, and salivary flow in patients with active rheumatoid arthritis: a pilot study |
| Q35233166 | The role of cytokines and their inhibitors in arthritis |
| Q35092953 | The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors. |
| Q38207758 | The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases |
| Q72065831 | The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis |
| Q35314485 | The search for laboratory measures of outcome in rheumatoid arthritis |
| Q35164732 | The therapeutic potential of TNF-alpha blockade in rheumatoid arthritis |
| Q96229604 | The trimer to monomer transition of Tumor Necrosis Factor-Alpha is a dynamic process that is significantly altered by therapeutic antibodies |
| Q47417568 | The urinary excretion of pyridinoline and deoxypyridinoline during rheumatoid arthritis therapy with infliximab. |
| Q61946761 | The −590 IL-4 promoter polymorphism in patients with rheumatoid arthritis |
| Q43161147 | Therapeutic effect of Linum usitatissimum (flaxseed/linseed) fixed oil on acute and chronic arthritic models in albino rats |
| Q35766628 | Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation |
| Q46577818 | Treatment for HTLV-I associated arthropathy: a case study and synovial tissue culture analysis |
| Q83299921 | Treatment with anti-TNF-alpha antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis |
| Q43760473 | Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook. f., suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human sy |
| Q71970994 | Tumor necrosis factor enhances the capsaicin sensitivity of rat sensory neurons |
| Q71325334 | Tumor necrosis factor-alpha (TNF-alpha) in canine osteoarthritis: Immunolocalization of TNF-alpha, stromelysin and TNF receptors in canine osteoarthritic cartilage |
| Q33178875 | Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts |
| Q73879531 | Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor |
| Q67875311 | Tumour necrosis factor alpha and interleukin-2 in plasma from rheumatoid arthritis patients in relation to disease activity |
| Q33564495 | Upregulation of insulin-like growth factor I gene expression in the lesions of osteoarthritic human articular cartilage |
| Q33578415 | Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone |
| Q34109021 | Use of biologics in the treatment of childhood rheumatic diseases |
| Q47685883 | Use of differential subtraction method to identify genes that characterize the phenotype of cultured rheumatoid arthritis synoviocytes |
| Q24793818 | VLA-4-dependent and -independent pathways in cell contact-induced proinflammatory cytokine production by synovial nurse-like cells from rheumatoid arthritis patients |
| Q43800675 | Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: critical involvement of the interaction with synovial fibroblasts |
| Q36920666 | Vascular endothelium, cytokines, and the pathogenesis of inflammatory synovitis |
| Q52291502 | Voltage-gated ionic channels in cultured rabbit articular chondrocytes. |
| Q71757411 | What turns on the endothelins? |
| Q71810340 | When Should Inhaled Corticosteroids Be Started for Asthma? |
| Q73969049 | [Production of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages from patients with rheumatoid arthritis and interstitial pulmonary disease] |
| Q37494553 | cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium |
Search more.